Shares of Harrow (HROW) have gained 5% over the past ... be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets ...

Harrow (HROW) stock plunged 20% post-market after the eye care drugmaker’s Q3 earnings report missed Street estimates on the ...

Analysts have been steadily raising their estimates for Harrow. Over the past three months, the Zacks Consensus Estimate for the company has increased 117.3%. Unlike the overly optimistic Wall ...